AI Enables Non-Invasive, Accurate Screening for Down Syndrome in the First Trimester

Down Syndrome, also known as Trisomy 21, is the most common chromosomal abnormality causing developmental delay and intellectual disability and can be identified in utero. Many pregnant women seek to determine whether their fetus has this abnormality.

Now researchers from the Institute of Automation of the Chinese Academy of Sciences (CASIA) have developed an intelligent prediction model to achieve non-invasive screening of Down Syndrome using ultrasound image.

This work was published in JAMA Network Open on June 21.

For decades, ultrasound images have been widely used for screening fetuses with Down Syndrome due to the method's safety, convenience, and low cost. However, using common ultrasound indicators, detection accuracy is less than 80% in actual ultrasound examinations.

Invasive methods such as villus biopsy, amniocentesis, and fetal umbilical venipuncture are also commonly used to detect Down Syndrome.

In this study, the researchers developed a convolutional neural network (CNN) to construct a deep learning (DL) model that could learn representative features from ultrasound images in order to identify fetuses with Down Syndrome.

A CNN is a deep learning algorithm that can take an input image, assign importance (i.e., learnable weights and biases) to various aspects/objects within the image and differentiate one from the other. A CNN can have tens or hundreds of hidden layers. The first layer learns how to detect edges and the last one learns how to detect more complex shapes. This research involved 11 hidden layers.

To further interpret the DL model in a human-readable form, the researchers also used a class activation map (CAM) to shed light on what the model focused on and how it explicitly enabled the CNN to learn discriminative features for risk scores.

The researchers used two-dimensional ultrasound images of the midsagittal plane of the fetal face between 11 and 14 weeks of gestation. Each image was segmented with a bounding box to show only the fetal head. The study comprised a total of 822 cases and controls, with 550 participants in the training set and 272 participants in the validation set.

The researchers found that the first five levels of feature maps visualized by CAM vividly showed the process of learning representative features. The CAM applied to the final layer showed the visualized response regions for the model's decision-making.

"This non-invasive screening model constructed for Down Syndrome in early pregnancy is significantly superior to existing, commonly used manual labeling markers, improving prediction accuracy by more than 15%. It's also superior to the current conventional invasive screening method for Down Syndrome based on maternal serum," said TIAN Jie, corresponding author of the study.

The proposed model is expected to become a non-invasive, inexpensive, and convenient screening tool for Down Syndrome in early pregnancy.

The research is supported by the National Natural Science Foundation of China and the Key R&D Program of the Ministry of Science and Technology.

Zhang L, Dong D, Sun Y, Hu C, Sun C, Wu Q, Tian J.
Development and Validation of a Deep Learning Model to Screen for Trisomy 21 During the First Trimester From Nuchal Ultrasonographic Images.
JAMA Netw Open. 2022 Jun 1;5(6):e2217854. doi: 10.1001/jamanetworkopen.2022.17854

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...